Core Cap Advisors, LLC Seagen Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $4,577 - $5,427	39 New	39 $5,000
Q2 2022 Aug 11, 2022	BUY	$108.81 - $179.33 $6,202 - $10,221	57 New	57 $10,000
Q1 2022 Apr 29, 2022	SELL	$119.61 - $157.85 $30,739 - $40,567	-257 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $36,640 - $49,051	257 New	257 $40,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.